Loading…
Mucoadhesive microspheres for nasal administration of cyclodextrins
The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing...
Saved in:
Published in: | Journal of drug targeting 2009-02, Vol.17 (2), p.168-179 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3 |
container_end_page | 179 |
container_issue | 2 |
container_start_page | 168 |
container_title | Journal of drug targeting |
container_volume | 17 |
creator | Gavini, Elisabetta Rassu, Giovanna Haukvik, Tone Lanni, Cristina Racchi, Marco Giunchedi, Paolo |
description | The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance. |
doi_str_mv | 10.1080/10611860802556842 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_10611860802556842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20363103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoPkZ_gBvpRnfV3GSStuhGBl-guFFwVzJ5MBnSZkxadf69KTMqIri6h8t3DvcehA4BnwIu8RlgDlDyJAljvByTDbQLmFQ5oRRvDppDnoCXHbQX4xxjoBzwNtqBsioZw3wXTR566YWa6WjfdNZYGXxczHTQMTM-ZK2IwmVCNba1sQuis77NvMnkUjqv9EcXbBv30ZYRLuqD9Ryh5-urp8ltfv94cze5vM_lmLMuZ8IUpdJ8zFhFgIEyinFWGkPSFvPpGEBVjAEFVRCsuSRaclaZokiiZFM6Qier3EXwr72OXd3YKLVzotW-jzXBlFPANIGwAodvYtCmXgTbiLCsAddDc_Wf5pLnaB3eTxutfhzrqhJwvAZElMKZIFpp4zdHALMKiiHoYsXZNjXYiHcfnKo7sXQ-fJnof3ec_7LPtHDdTIqg67nvQ5sK_ueLTxqkmyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20363103</pqid></control><display><type>article</type><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</creator><creatorcontrib>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</creatorcontrib><description>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</description><identifier>ISSN: 1061-186X</identifier><identifier>EISSN: 1029-2330</identifier><identifier>DOI: 10.1080/10611860802556842</identifier><identifier>PMID: 18985506</identifier><language>eng</language><publisher>London: Informa UK Ltd</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Adhesiveness ; Adhesives - chemistry ; Alginates - chemistry ; Amyloid beta-Peptides - pharmacology ; Animals ; beta-Cyclodextrins - administration & dosage ; beta-Cyclodextrins - chemistry ; Biological and medical sciences ; Brain - metabolism ; brain targeting ; Cell Line, Tumor ; Chitosan - chemistry ; Cyclodextrin ; Drug Compounding ; Drug Delivery Systems ; General pharmacology ; Humans ; Lasers ; Light ; Medical sciences ; Microscopy, Electron, Scanning ; Microspheres ; mucoadhesive microspheres ; nasal drug delivery ; Nasal Mucosa - chemistry ; nose-to-brain transport ; Particle Size ; Permeability ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymers - chemistry ; Scattering, Radiation ; Sheep</subject><ispartof>Journal of drug targeting, 2009-02, Vol.17 (2), p.168-179</ispartof><rights>2009 Informa UK Ltd 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</citedby><cites>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21059172$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18985506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gavini, Elisabetta</creatorcontrib><creatorcontrib>Rassu, Giovanna</creatorcontrib><creatorcontrib>Haukvik, Tone</creatorcontrib><creatorcontrib>Lanni, Cristina</creatorcontrib><creatorcontrib>Racchi, Marco</creatorcontrib><creatorcontrib>Giunchedi, Paolo</creatorcontrib><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><title>Journal of drug targeting</title><addtitle>J Drug Target</addtitle><description>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Adhesiveness</subject><subject>Adhesives - chemistry</subject><subject>Alginates - chemistry</subject><subject>Amyloid beta-Peptides - pharmacology</subject><subject>Animals</subject><subject>beta-Cyclodextrins - administration & dosage</subject><subject>beta-Cyclodextrins - chemistry</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>brain targeting</subject><subject>Cell Line, Tumor</subject><subject>Chitosan - chemistry</subject><subject>Cyclodextrin</subject><subject>Drug Compounding</subject><subject>Drug Delivery Systems</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lasers</subject><subject>Light</subject><subject>Medical sciences</subject><subject>Microscopy, Electron, Scanning</subject><subject>Microspheres</subject><subject>mucoadhesive microspheres</subject><subject>nasal drug delivery</subject><subject>Nasal Mucosa - chemistry</subject><subject>nose-to-brain transport</subject><subject>Particle Size</subject><subject>Permeability</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymers - chemistry</subject><subject>Scattering, Radiation</subject><subject>Sheep</subject><issn>1061-186X</issn><issn>1029-2330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMoPkZ_gBvpRnfV3GSStuhGBl-guFFwVzJ5MBnSZkxadf69KTMqIri6h8t3DvcehA4BnwIu8RlgDlDyJAljvByTDbQLmFQ5oRRvDppDnoCXHbQX4xxjoBzwNtqBsioZw3wXTR566YWa6WjfdNZYGXxczHTQMTM-ZK2IwmVCNba1sQuis77NvMnkUjqv9EcXbBv30ZYRLuqD9Ryh5-urp8ltfv94cze5vM_lmLMuZ8IUpdJ8zFhFgIEyinFWGkPSFvPpGEBVjAEFVRCsuSRaclaZokiiZFM6Qier3EXwr72OXd3YKLVzotW-jzXBlFPANIGwAodvYtCmXgTbiLCsAddDc_Wf5pLnaB3eTxutfhzrqhJwvAZElMKZIFpp4zdHALMKiiHoYsXZNjXYiHcfnKo7sXQ-fJnof3ec_7LPtHDdTIqg67nvQ5sK_ueLTxqkmyQ</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Gavini, Elisabetta</creator><creator>Rassu, Giovanna</creator><creator>Haukvik, Tone</creator><creator>Lanni, Cristina</creator><creator>Racchi, Marco</creator><creator>Giunchedi, Paolo</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090201</creationdate><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><author>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Adhesiveness</topic><topic>Adhesives - chemistry</topic><topic>Alginates - chemistry</topic><topic>Amyloid beta-Peptides - pharmacology</topic><topic>Animals</topic><topic>beta-Cyclodextrins - administration & dosage</topic><topic>beta-Cyclodextrins - chemistry</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>brain targeting</topic><topic>Cell Line, Tumor</topic><topic>Chitosan - chemistry</topic><topic>Cyclodextrin</topic><topic>Drug Compounding</topic><topic>Drug Delivery Systems</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lasers</topic><topic>Light</topic><topic>Medical sciences</topic><topic>Microscopy, Electron, Scanning</topic><topic>Microspheres</topic><topic>mucoadhesive microspheres</topic><topic>nasal drug delivery</topic><topic>Nasal Mucosa - chemistry</topic><topic>nose-to-brain transport</topic><topic>Particle Size</topic><topic>Permeability</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymers - chemistry</topic><topic>Scattering, Radiation</topic><topic>Sheep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gavini, Elisabetta</creatorcontrib><creatorcontrib>Rassu, Giovanna</creatorcontrib><creatorcontrib>Haukvik, Tone</creatorcontrib><creatorcontrib>Lanni, Cristina</creatorcontrib><creatorcontrib>Racchi, Marco</creatorcontrib><creatorcontrib>Giunchedi, Paolo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of drug targeting</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavini, Elisabetta</au><au>Rassu, Giovanna</au><au>Haukvik, Tone</au><au>Lanni, Cristina</au><au>Racchi, Marco</au><au>Giunchedi, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mucoadhesive microspheres for nasal administration of cyclodextrins</atitle><jtitle>Journal of drug targeting</jtitle><addtitle>J Drug Target</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>17</volume><issue>2</issue><spage>168</spage><epage>179</epage><pages>168-179</pages><issn>1061-186X</issn><eissn>1029-2330</eissn><abstract>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</abstract><cop>London</cop><pub>Informa UK Ltd</pub><pmid>18985506</pmid><doi>10.1080/10611860802556842</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1061-186X |
ispartof | Journal of drug targeting, 2009-02, Vol.17 (2), p.168-179 |
issn | 1061-186X 1029-2330 |
language | eng |
recordid | cdi_crossref_primary_10_1080_10611860802556842 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | 2-Hydroxypropyl-beta-cyclodextrin Adhesiveness Adhesives - chemistry Alginates - chemistry Amyloid beta-Peptides - pharmacology Animals beta-Cyclodextrins - administration & dosage beta-Cyclodextrins - chemistry Biological and medical sciences Brain - metabolism brain targeting Cell Line, Tumor Chitosan - chemistry Cyclodextrin Drug Compounding Drug Delivery Systems General pharmacology Humans Lasers Light Medical sciences Microscopy, Electron, Scanning Microspheres mucoadhesive microspheres nasal drug delivery Nasal Mucosa - chemistry nose-to-brain transport Particle Size Permeability Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polymers - chemistry Scattering, Radiation Sheep |
title | Mucoadhesive microspheres for nasal administration of cyclodextrins |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A49%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mucoadhesive%20microspheres%20for%20nasal%20administration%20of%20cyclodextrins&rft.jtitle=Journal%20of%20drug%20targeting&rft.au=Gavini,%20Elisabetta&rft.date=2009-02-01&rft.volume=17&rft.issue=2&rft.spage=168&rft.epage=179&rft.pages=168-179&rft.issn=1061-186X&rft.eissn=1029-2330&rft_id=info:doi/10.1080/10611860802556842&rft_dat=%3Cproquest_cross%3E20363103%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20363103&rft_id=info:pmid/18985506&rfr_iscdi=true |